iBio Inc (AMEX:IBIO)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 1.46. At the close of trading, the stock’s price was $3.72, to imply an increase of 3.62% or $0.13 in intraday trading. The IBIO share’s 52-week high remains $4.98, putting it -33.87% down since that peak but still an impressive 71.77% since price per share fell to its 52-week low of $1.05. The company has a valuation of $36.58M, with an average of 0.3 million shares in intraday trading volume over the past 10 days and average of 171.05K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for iBio Inc (IBIO), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give IBIO a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.45.
iBio Inc (AMEX:IBIO) trade information
After registering a 3.62% upside in the last session, iBio Inc (IBIO) has traded red over the past five days. The 5-day price performance for the stock is 23.59%, and 37.27% over 30 days. With these gigs, the year-to-date price performance is 51.84%. Short interest in iBio Inc (AMEX:IBIO) saw shorts transact 0.24 million shares and set a 1.91 days time to cover.
The extremes give us $3.6 and $3.6 for target low and target high price respectively. As such, IBIO has been trading 3.23% off suggested target high and 3.23% from its likely low.
iBio Inc (IBIO) estimates and forecasts
The rating firms project that company’s revenue will shrink -100.00% compared to the previous financial year.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 57.55% for the past 5-year period. While 2025 is set for a 62.28% return in earnings, projections for the next 5 years are at 45.85% annually.
IBIO Dividends
iBio Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
iBio Inc (AMEX:IBIO)’s Major holders
iBio Inc insiders hold 7.58% of total outstanding shares, with institutional holders owning 30.88% of the shares at 33.41% float percentage. In total, 30.88% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the iBio Inc (IBIO) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 47.16 shares. This is just over 0.48% of the total shares, with a market valuation of $0.18 million. Data from the same date shows that the other fund manager holds a little less at 36.0, or 0.37% of the shares, all valued at about 0.13 million.
